Tarsus Pharmaceuticals, Inc. (TARS) NASDAQ

Currency In USD

Tarsus Pharmaceuticals, Inc.

Address

15440 Laguna Canyon Road

Irvine, CA 92618

United States of America (the)

Phone

949 409 9820

Website

https://www.tarsusrx.com

Sector

Healthcare

Industry

Biotechnology

Employees

323

First IPO Date

October 16, 2020

Key Executives

Name	Title	Pay	Year Born
Bobak R. Azamian	Co-Founder, President, Chief Executive Officer & Chairman	1.32M	N/A
Elizabeth Yeu	Chief Medical Officer	156,691	1979
Dianne C. Whitfield	Chief Human Resources Officer	578,900	1977
Bryan Wahl	General Counsel & Corporate Secretary	771,233	1978
Aziz Mottiwala	Chief Commercial Officer	821,650	1978
Seshadri Neervannan	Chief Operating Officer	839,200	1968
Jeffrey S. Farrow	Chief Financial Officer & Chief Strategy Officer	888,645	1962
Scott Youmans	Vice President of Sales	0	N/A
Adrienne Kemp	Senior Director of Corporate Communications	0	N/A
Cara Miller	Senior Vice President of Corporate Affairs	0	N/A
Neera Clase	Senior Vice President of Market Access	0	N/A
David Nakasone	Head of Investor Relations	0	N/A
Matthew Rossen	Vice President of Marketing	0	1978

Description

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.